{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T22:03:40Z","timestamp":1780524220775,"version":"3.54.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["LQ24H090003"],"award-info":[{"award-number":["LQ24H090003"]}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2023FZZX05-02"],"award-info":[{"award-number":["2023FZZX05-02"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302081"],"award-info":[{"award-number":["82302081"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s00415-024-12779-2","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T12:17:49Z","timestamp":1734005869000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Longitudinal associations between cerebrospinal fluid glial activation markers, depression, and dopamine transporter availability in patients with Parkinson\u2019s disease"],"prefix":"10.1007","volume":"272","author":[{"given":"Dehao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junli","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingsheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangjing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoqiao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoyi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linxuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhu","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1818-6280","authenticated-orcid":false,"given":"Guangyong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,12]]},"reference":[{"key":"12779_CR1","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C (2021) Parkinson\u2019s disease. Lancet 397:2284\u20132303","journal-title":"Lancet"},{"key":"12779_CR2","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s00018-022-04240-2","volume":"79","author":"GK Tofaris","year":"2022","unstructured":"Tofaris GK (2022) Initiation and progression of \u03b1-synuclein pathology in Parkinson\u2019s disease. Cell Mol Life Sci 79:210","journal-title":"Cell Mol Life Sci"},{"key":"12779_CR3","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S (2003) Parkinson\u2019s disease: mechanisms and models. Neuron 39:889\u2013909","journal-title":"Neuron"},{"key":"12779_CR4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","volume":"9","author":"HS Kwon","year":"2020","unstructured":"Kwon HS, Koh SH (2020) Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Transl Neurodegener 9:42","journal-title":"Transl Neurodegener"},{"key":"12779_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2022.104749","volume":"141","author":"S Cong","year":"2022","unstructured":"Cong S, Xiang C, Zhang S, Zhang T, Wang H, Cong S (2022) Prevalence and clinical aspects of depression in Parkinson\u2019s disease: a systematic review and meta-analysis of 129 studies. Neurosci Biobehav Rev 141:104749","journal-title":"Neurosci Biobehav Rev"},{"key":"12779_CR6","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s12877-017-0666-2","volume":"17","author":"SS Cui","year":"2017","unstructured":"Cui SS, Du JJ, Fu R, Lin YQ, Huang P, He YC et al (2017) Prevalence and risk factors for depression and anxiety in Chinese patients with Parkinson disease. BMC Geriatr 17:270","journal-title":"BMC Geriatr"},{"key":"12779_CR7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neubiorev.2019.04.002","volume":"102","author":"CPC Galts","year":"2019","unstructured":"Galts CPC, Bettio LEB, Jewett DC, Yang CC, Brocardo PS, Rodrigues ALS et al (2019) Depression in neurodegenerative diseases: common mechanisms and current treatment options. Neurosci Biobehav Rev 102:56\u201384","journal-title":"Neurosci Biobehav Rev"},{"key":"12779_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aam6003","author":"AS Chen-Plotkin","year":"2018","unstructured":"Chen-Plotkin AS, Albin R, Alcalay R, Babcock D, Bajaj V, Bowman D et al (2018) Finding useful biomarkers for Parkinson\u2019s disease. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aam6003","journal-title":"Sci Transl Med"},{"key":"12779_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101840","volume":"85","author":"MH Ahmad","year":"2023","unstructured":"Ahmad MH, Rizvi MA, Ali M, Mondal AC (2023) Neurobiology of depression in Parkinson\u2019s disease: insights into epidemiology, molecular mechanisms and treatment strategies. Ageing Res Rev 85:101840","journal-title":"Ageing Res Rev"},{"key":"12779_CR10","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.bbi.2020.11.007","volume":"91","author":"ZH Zheng","year":"2021","unstructured":"Zheng ZH, Tu JL, Li XH, Hua Q, Liu WZ, Liu Y et al (2021) Neuroinflammation induces anxiety- and depressive-like behavior by modulating neuronal plasticity in the basolateral amygdala. Brain Behav Immun 91:505\u2013518","journal-title":"Brain Behav Immun"},{"key":"12779_CR11","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.neuron.2020.06.002","volume":"107","author":"E Beurel","year":"2020","unstructured":"Beurel E, Toups M, Nemeroff CB (2020) The bidirectional relationship of depression and inflammation: double trouble. Neuron 107:234\u2013256","journal-title":"Neuron"},{"key":"12779_CR12","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.tins.2015.08.001","volume":"38","author":"R Yirmiya","year":"2015","unstructured":"Yirmiya R, Rimmerman N, Reshef R (2015) Depression as a microglial disease. Trends Neurosci 38:637\u2013658","journal-title":"Trends Neurosci"},{"key":"12779_CR13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/emm.2006.40","volume":"38","author":"YS Kim","year":"2006","unstructured":"Kim YS, Joh TH (2006) Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson\u2019s disease. Exp Mol Med 38:333\u2013347","journal-title":"Exp Mol Med"},{"key":"12779_CR14","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.bbi.2019.07.026","volume":"81","author":"Z Liu","year":"2019","unstructured":"Liu Z, Qiu AW, Huang Y, Yang Y, Chen JN, Gu TT et al (2019) IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson\u2019s disease. Brain Behav Immun 81:630\u2013645","journal-title":"Brain Behav Immun"},{"key":"12779_CR15","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1016\/j.neuron.2023.09.004","volume":"111","author":"Y Dong","year":"2023","unstructured":"Dong Y, Li Y, Xiang X, Xiao ZC, Hu J, Li Y et al (2023) Stress relief as a natural resilience mechanism against depression-like behaviors. Neuron 111:3789-3801.e3786","journal-title":"Neuron"},{"key":"12779_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.neuron.2023.10.002","volume":"112","author":"M Wu","year":"2024","unstructured":"Wu M, Zhang X, Feng S, Freda SN, Kumari P, Dumrongprechachan V et al (2024) Dopamine pathways mediating affective state transitions after sleep loss. Neuron 112:141-154.e148","journal-title":"Neuron"},{"key":"12779_CR17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41531-023-00509-w","volume":"9","author":"F Paolini Paoletti","year":"2023","unstructured":"Paolini Paoletti F, Gaetani L, Bellomo G, Chipi E, Salvadori N, Montanucci C et al (2023) CSF neurochemical profile and cognitive changes in Parkinson\u2019s disease with mild cognitive impairment. NPJ Parkinsons Dis 9:68","journal-title":"NPJ Parkinsons Dis"},{"key":"12779_CR18","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12974-020-01878-2","volume":"17","author":"J Yang","year":"2020","unstructured":"Yang J, Fu Z, Zhang X, Xiong M, Meng L, Zhang Z (2020) TREM2 ectodomain and its soluble form in Alzheimer\u2019s disease. J Neuroinflammation 17:204","journal-title":"J Neuroinflammation"},{"key":"12779_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/alz.12612","volume":"19","author":"K Connolly","year":"2023","unstructured":"Connolly K, Lehoux M, O\u2019Rourke R, Assetta B, Erdemir GA, Elias JA et al (2023) Potential role of chitinase-3-like protein 1 (CHI3L1\/YKL-40) in neurodegeneration and Alzheimer\u2019s disease. Alzheimers Dement 19:9\u201324","journal-title":"Alzheimers Dement"},{"key":"12779_CR20","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s12974-023-02970-z","volume":"20","author":"X Zeng","year":"2023","unstructured":"Zeng X, Cheung SKK, Shi M, Or PMY, Li Z, Liu JYH et al (2023) Astrocyte-specific knockout of YKL-40\/Chi3l1 reduces A\u03b2 burden and restores memory functions in 5xFAD mice. J Neuroinflammation 20:290","journal-title":"J Neuroinflammation"},{"key":"12779_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/brain\/awad321","volume":"147","author":"C Qin","year":"2024","unstructured":"Qin C, Chen M, Dong MH, Yang S, Zhang H, You YF et al (2024) Soluble TREM2 triggers microglial dysfunction in neuromyelitis optica spectrum disorders. Brain 147:163\u2013176","journal-title":"Brain"},{"key":"12779_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.892493","volume":"14","author":"Q Qin","year":"2022","unstructured":"Qin Q, Wan H, Wang D, Li J, Qu Y, Zhao J et al (2022) The association of CSF sTREM2 with cognitive decline and its dynamic change in Parkinson\u2019s disease: analysis of the PPMI cohort. Front Aging Neurosci 14:892493","journal-title":"Front Aging Neurosci"},{"key":"12779_CR23","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/mds.26578","volume":"31","author":"S Hall","year":"2016","unstructured":"Hall S, Surova Y, \u00d6hrfelt A, Blennow K, Zetterberg H, Hansson O (2016) Longitudinal measurements of cerebrospinal fluid biomarkers in Parkinson\u2019s disease. Mov Disord 31:898\u2013905","journal-title":"Mov Disord"},{"key":"12779_CR24","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","volume":"95","author":"Parkinson Progression Marker Initiative","year":"2011","unstructured":"Parkinson Progression Marker Initiative (2011) The Parkinson progression marker initiative (PPMI). Prog Neurobiol 95:629\u2013635","journal-title":"Prog Neurobiol"},{"key":"12779_CR25","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1002\/acn3.644","volume":"5","author":"K Marek","year":"2018","unstructured":"Marek K, Chowdhury S, Siderowf A, Lasch S, Coffey CS, Caspell-Garcia C et al (2018) The Parkinson\u2019s progression markers initiative (PPMI)\u2014establishing a PD biomarker cohort. Ann Clin Transl Neurol 5:1460\u20131477","journal-title":"Ann Clin Transl Neurol"},{"key":"12779_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0257372","volume":"16","author":"M Bartl","year":"2021","unstructured":"Bartl M, Dakna M, Galasko D, Hutten SJ, Foroud T, Quan M et al (2021) Biomarkers of neurodegeneration and glial activation validated in Alzheimer\u2019s disease assessed in longitudinal cerebrospinal fluid samples of Parkinson\u2019s disease. PLoS ONE 16:e0257372","journal-title":"PLoS ONE"},{"key":"12779_CR27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/01.JGP.0000192488.66049.4b","volume":"14","author":"D Weintraub","year":"2006","unstructured":"Weintraub D, Oehlberg KA, Katz IR, Stern MB (2006) Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson disease. Am J Geriatr Psychiatry 14:169\u2013175","journal-title":"Am J Geriatr Psychiatry"},{"key":"12779_CR28","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1136\/jnnp-2022-330790","volume":"94","author":"H Costello","year":"2023","unstructured":"Costello H, Yamamori Y, Reeves S, Schrag AE, Howard R, Roiser JP (2023) Longitudinal decline in striatal dopamine transporter binding in Parkinson\u2019s disease: associations with apathy and anhedonia. J Neurol Neurosurg Psychiatry 94:863\u2013870","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12779_CR29","doi-asserted-by":"publisher","first-page":"33027","DOI":"10.1074\/jbc.M113.517540","volume":"288","author":"P Wunderlich","year":"2013","unstructured":"Wunderlich P, Glebov K, Kemmerling N, Tien NT, Neumann H, Walter J (2013) Sequential proteolytic processing of the triggering receptor expressed on myeloid cells-2 (TREM2) protein by ectodomain shedding and \u03b3-secretase-dependent intramembranous cleavage. J Biol Chem 288:33027\u201333036","journal-title":"J Biol Chem"},{"key":"12779_CR30","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1084\/jem.20160844","volume":"214","author":"L Zhong","year":"2017","unstructured":"Zhong L, Chen XF, Wang T, Wang Z, Liao C, Wang Z et al (2017) Soluble TREM2 induces inflammatory responses and enhances microglial survival. J Exp Med 214:597\u2013607","journal-title":"J Exp Med"},{"key":"12779_CR31","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jare.2022.03.011","volume":"44","author":"H Zhou","year":"2023","unstructured":"Zhou H, Li J, Hu L, Yu J, Fu X, Liang F et al (2023) Soluble Trem2 is a negative regulator of erythrophagocytosis after intracerebral hemorrhage in a CD36 receptor recycling manner. J Adv Res 44:185\u2013199","journal-title":"J Adv Res"},{"key":"12779_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105630","volume":"165","author":"F Filipello","year":"2022","unstructured":"Filipello F, Goldsbury C, You SF, Locca A, Karch CM, Piccio L (2022) Soluble TREM2: innocent bystander or active player in neurological diseases? Neurobiol Dis 165:105630","journal-title":"Neurobiol Dis"},{"key":"12779_CR33","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax3519","author":"BV Lananna","year":"2020","unstructured":"Lananna BV, McKee CA, King MW, Del-Aguila JL, Dimitry JM, Farias FHG et al (2020) Chi3l1\/YKL-40 is controlled by the astrocyte circadian clock and regulates neuroinflammation and Alzheimer\u2019s disease pathogenesis. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aax3519","journal-title":"Sci Transl Med"},{"key":"12779_CR34","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jad.2021.06.030","volume":"293","author":"S Teipel","year":"2021","unstructured":"Teipel S, Bruno D, Plaska CR, Heslegrave A, Ramos-Cejudo J, Osorio RS et al (2021) Association of CSF sTREM2, a marker of microglia activation, with cholinergic basal forebrain volume in major depressive disorder. J Affect Disord 293:429\u2013434","journal-title":"J Affect Disord"},{"key":"12779_CR35","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1523\/JNEUROSCI.1184-19.2019","volume":"40","author":"TW Schmitz","year":"2020","unstructured":"Schmitz TW, Soreq H, Poirier J, Spreng RN (2020) Longitudinal basal forebrain degeneration interacts with TREM2\/C3 biomarkers of inflammation in presymptomatic Alzheimer\u2019s disease. J Neurosci 40:1931\u20131942","journal-title":"J Neurosci"},{"key":"12779_CR36","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1176\/ajp.133.10.1197","volume":"133","author":"FG Guggenheim","year":"1976","unstructured":"Guggenheim FG, O\u2019Hara S (1976) Peer counseling in a general hospital. Am J Psychiatry 133:1197\u20131199","journal-title":"Am J Psychiatry"},{"key":"12779_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.neuron.2009.09.002","volume":"64","author":"BE Deverman","year":"2009","unstructured":"Deverman BE, Patterson PH (2009) Cytokines and CNS development. Neuron 64:61\u201378","journal-title":"Neuron"},{"key":"12779_CR38","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.tins.2012.08.001","volume":"35","author":"BM Elmer","year":"2012","unstructured":"Elmer BM, McAllister AK (2012) Major histocompatibility complex class I proteins in brain development and plasticity. Trends Neurosci 35:660\u2013670","journal-title":"Trends Neurosci"},{"key":"12779_CR39","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer R, O\u2019Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9:46\u201356","journal-title":"Nat Rev Neurosci"},{"key":"12779_CR40","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.tics.2019.03.003","volume":"23","author":"MT Treadway","year":"2019","unstructured":"Treadway MT, Cooper JA, Miller AH (2019) Can\u2019t or won\u2019t? Immunometabolic constraints on dopaminergic drive. Trends Cogn Sci 23:435\u2013448","journal-title":"Trends Cogn Sci"},{"key":"12779_CR41","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/npp.2016.143","volume":"42","author":"JC Felger","year":"2017","unstructured":"Felger JC, Treadway MT (2017) Inflammation effects on motivation and motor activity: role of dopamine. Neuropsychopharmacology 42:216\u2013241","journal-title":"Neuropsychopharmacology"},{"key":"12779_CR42","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200785","author":"S Wang","year":"2020","unstructured":"Wang S, Mustafa M, Yuede CM, Salazar SV, Kong P, Long H et al (2020) Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer\u2019s disease model. J Exp Med. https:\/\/doi.org\/10.1084\/jem.20200785","journal-title":"J Exp Med"},{"key":"12779_CR43","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1474-4422(23)00247-8","volume":"22","author":"K Schlepckow","year":"2023","unstructured":"Schlepckow K, Morenas-Rodr\u00edguez E, Hong S, Haass C (2023) Stimulation of TREM2 with agonistic antibodies-an emerging therapeutic option for Alzheimer\u2019s disease. Lancet Neurol 22:1048\u20131060","journal-title":"Lancet Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12779-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-024-12779-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12779-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T17:55:11Z","timestamp":1738173311000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-024-12779-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,12]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["12779"],"URL":"https:\/\/doi.org\/10.1007\/s00415-024-12779-2","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,12]]},"assertion":[{"value":"23 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author(s) declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Data used in the preparation of this article were obtained on [2023-08-19] from the PPMI database (), RRID: SCR_006431. For up-to-date information on the study, visit http:\/\/www.ppmi-info.org. All participating institutions\u2019 regional ethical committees approved the PPMI, and written informed consent were obtained from all study participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"23"}}